Anthony Lambert
Physician Assistant · Lake City, FLNPI 1982691218
Payments from drug & device makers
Across 238 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Lilly USA, LLC$547
- AbbVie$266
- Pfizer$247
- Medtronic$176
- Sanofi-aventis U.S. LLC$126
- plus $1K from 23 others
What the payments were for
- Food & beverage$4,103100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 99 | $1,477 |
| Lilly USA, LLC | 32 | $547 |
| AbbVie | 13 | $266 |
| Pfizer | 12 | $247 |
| Medtronic | 3 | $176 |
| Sanofi-aventis U.S. LLC | 7 | $126 |
| Exact Sciences | 8 | $123 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $122 |
| Grifols USA, LLC | 7 | $119 |
| GSK | 5 | $100 |
| Merck | 5 | $75 |
| Bayer | 4 | $72 |
| Johnson & Johnson | 4 | $63 |
| Astellas Pharma US Inc | 3 | $58 |
| Abbott | 3 | $57 |
| Boehringer Ingelheim | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Biogen | 3 | $47 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $44 |
| AstraZeneca(2 entities) | 2 | $44 |
| Amgen | 3 | $44 |
| Radius Health, Inc. | 1 | $34 |
| Boston Scientific | 2 | $32 |
| Dexcom, Inc. | 1 | $27 |
| Novartis | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,103 in reported general payments places this provider in the 85th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 90 | $100,362 |
| JardianceEmpagliflozin | 59 | $61,413 |
| MounjaroTirzepatide | 39 | $41,206 |
| EliquisApixaban | 32 | $36,615 |
| TrulicityDulaglutide | 14 | $35,679 |
| FarxigaDapagliflozin Propanediol | 35 | $25,156 |
| RybelsusSemaglutide | 21 | $24,398 |
| XareltoRivaroxaban | 34 | $23,878 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 28 | $21,723 |
| MyrbetriqMirabegron | 25 | $18,787 |
| SymbicortBudesonide/Formoterol Fumarate | 30 | $17,919 |
| JanuviaSitagliptin Phosphate | 18 | $16,719 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 29 | $15,607 |
| Tresiba Flextouch U-200Insulin Degludec | 15 | $15,470 |
| LinzessLinaclotide | 18 | $13,194 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,477 | $124,761111 claims |
| Lilly USA, LLCMounjaro, Trulicity | $547 | $76,88553 claims |
| Boehringer IngelheimJardiance | $53 | $61,41359 claims |
| AstraZenecaFarxiga, Symbicort | $44 | $43,07565 claims |
| PfizerEliquis | $247 | $36,61532 claims |
| Johnson & JohnsonXarelto | $63 | $23,87834 claims |
| GSKTrelegy Ellipta | $100 | $21,72328 claims |
| Astellas Pharma US IncMyrbetriq | $58 | $18,78725 claims |
| MerckJanuvia | $75 | $16,71918 claims |
| AbbVieLinzess, Synthroid | $266 | $15,16837 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in Lake City
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
- Ashley MillerGainesville$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.